Drug Shortage Report for TEVA-AMPHETAMINE XR
| Report ID | 236401 |
| Drug Identification Number | 02439263 |
| Brand name | TEVA-AMPHETAMINE XR |
| Common or Proper name | AMPHETAMINE XR 20MG CAPS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MIXED SALTS AMPHETAMINE |
| Strength(s) | 20MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N06BA |
| ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-08-28 |
| Estimated end date | 2025-11-10 |
| Actual end date | 2025-11-12 |
| Shortage status | Resolved |
| Updated date | 2025-11-13 |
| Company comments | Under Allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v36 | 2025-11-13 | French | Compare |
| v35 | 2025-11-13 | English | Compare |
| v34 | 2025-10-23 | French | Compare |
| v33 | 2025-10-23 | English | Compare |
| v32 | 2025-10-10 | French | Compare |
| v31 | 2025-10-10 | English | Compare |
| v30 | 2025-10-02 | French | Compare |
| v29 | 2025-10-02 | English | Compare |
| v28 | 2025-07-03 | French | Compare |
| v27 | 2025-07-03 | English | Compare |
| v26 | 2025-06-19 | French | Compare |
| v25 | 2025-06-19 | English | Compare |
| v24 | 2025-05-30 | French | Compare |
| v23 | 2025-05-30 | English | Compare |
| v22 | 2025-05-28 | French | Compare |
| v21 | 2025-05-28 | English | Compare |
| v20 | 2025-04-24 | French | Compare |
| v19 | 2025-04-24 | English | Compare |
| v18 | 2025-04-04 | French | Compare |
| v17 | 2025-04-04 | English | Compare |